Helsinn publishes new data evaluating chlormethine gel's mode of action in Dermatology and Therapy
yahoo.com
science
2022-10-18 12:00:00

Helsinn Healthcare S.A.

Helsinn publishes new data evaluating chlormethine gel's mode of action in Dermatology and Therapy

Lugano, Switzerland, October 18, 2022 - Helsinn Group ('Helsinn'), a fully integrated, global biopharma company with a diversified pipeline of innovative oncology assets, announces that research from an in vitro study of chlormethine gel has been published in the journal Dermatology and Therapy.

This article, 'Chlormethine Gel for the treatment of Mycosis Fungoides Cutaneous T-Cell Lymphoma: In Vitro Release and Permeation Testing', evaluated part of the mode of action of chlormethine (CL) gel once applied to the skin.
